DNA Genotek
Graham Morse is a seasoned professional in the field of product research and development with extensive experience in the chemical engineering sector, currently serving as the Director of Product R&D at DNA Genotek since May 2021. Prior to this, Graham held the position of Director and Head of Single Use Chromatography R&D at MilliporeSigma from March 2019 to May 2021. Graham's tenure at Merck Group spanned from September 2012 to March 2019, where roles included Director and Head of Formulations UK, R&D Manager focused on organic photovoltaic materials, and team leader in physics fundamentals R&D. Academic achievements include a PhD in Chemical Engineering & Applied Chemistry from the University of Toronto (2007-2012) and undergraduate studies at the University of Ottawa (2003-2007). Graham has contributed to significant advancements in organic solar cell technologies through various roles in research, including international collaboration as a PhD Visiting Researcher at the University of Arizona.
This person is not in any teams
DNA Genotek
DNA Genotek, a subsidiary of OraSure Technologies, Inc., develops products that optimize ease of collection and provide superior samples and proven performance for those requiring high-quality biological samples for nucleic acid testing for both human genomics and microbiome. High-quality samples that are easily collected from target populations enable our customers to focus on translating their analysis and testing into significant worldwide advancements in health and science. DNA Genotek's success is based on our strong relationship with our valued customers, our innovative environment and our passion for quality. Today, DNA Genotek products are marketed worldwide and support thousands of customers as they achieve breakthroughs in genomic research, in diagnostics laboratories, in the pharmaceutical industry, in livestock and animal genomics, and in personal genomics. Consequently, our products provide our customers with the ability to focus on solving disease, disease prevention and treatment by translating their testing into worldwide health improvements. © 2018 DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc., all rights reserved.